Faeth Therapeutics, Inc. (FTH)

Data as of Sep 15, 2026, from SEC Form 4 filings.

No open-market insider trades (90d)Watch FTH

See up to 3 months of FTH. The 7-day demo opens the 1M and 3M ranges and puts FTH on your watchlist.

Latest FTH insider trades

Brian C. Stephenson - Officer
Open-market purchase$19K
Jun 29, 2026
Brian C. Stephenson - Officer
Open-market purchase$44K
Jun 30, 2026

About Faeth Therapeutics, Inc. (FTH)

The SEC lists Faeth Therapeutics, Inc. under CIK 0001829802, in pharmaceutical preparations. It is grouped with Health Care companies on this site.

Sector: Health Care

SEC filings for FTH on EDGAR

FTH Form 4 activity by transaction type, last 90 days

Form 4 transaction type	Transactions	Shares	Total value
Grant or award	3	453,842

Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.

FTH insider transactions (Form 4)

26 Form 4 filings on record, the earliest from Dec 23, 2024, newest first.

Date	Insider	Transaction	Security	Shares	Price	Value
Sep 11, 2026	Karen H. Vousden - Director	Grant or award	Stock Option (right to buy)	25,000	$0.00	-
Jul 21, 2026	Josiah Craver - Officer	Grant or award	Performance-Based Stock Option (right to buy)	30,824	$0.00	-
Jul 21, 2026	Anand Kiran Parikh - Officer	Grant or award	Performance-Based Stock Option (right to buy)	398,018	$0.00	-
Jun 29, 2026	Brian C. Stephenson - Officer	Open-market purchase	Common Stock	831	$23.34^{footnote F1}	$19K
Jun 30, 2026	Brian C. Stephenson - Officer	Open-market purchase	Common Stock	1,910	$22.95^{footnote F3}	$44K
Jun 30, 2026	Brian C. Stephenson - Officer	Open-market purchase	Common Stock	1,638	$23.88^{footnote F4}	$39K
Jun 30, 2026	Brian C. Stephenson - Officer	Open-market purchase	Common Stock	4,255	$24.98^{footnote F5}	$106K
Jul 1, 2026	Brian C. Stephenson - Officer	Open-market purchase	Common Stock	4,400	$23.40^{footnote F6}	$103K
Jul 1, 2026	Brian C. Stephenson - Officer	Open-market purchase	Common Stock	600	$24.22^{footnote F7}	$15K
Footnote F1 (price): The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $23.20 to $23.49, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the… Full note on SEC EDGAR Footnote F3 (price): The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $22.45 to $23.28, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the… Full note on SEC EDGAR Footnote F4 (price): The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $23.50 to $24.40, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the… Full note on SEC EDGAR Footnote F5 (price): The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $24.59 to $25.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the… Full note on SEC EDGAR Footnote F6 (price): The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $23.14 to $23.94, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the… Full note on SEC EDGAR Footnote F7 (price): The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $24.14 to $24.29, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the… Full note on SEC EDGAR
Jun 24, 2026	Brian C. Stephenson - Officer	Open-market purchase	Common Stock	2,891	$25.22^{footnote F1}	$73K
Jun 24, 2026	Brian C. Stephenson - Officer	Open-market purchase	Common Stock	3,000	$25.98^{footnote F3}	$78K
Jun 24, 2026	Brian C. Stephenson - Officer	Open-market purchase	Common Stock	3,400	$26.98^{footnote F4}	$92K
Jun 24, 2026	Brian C. Stephenson - Officer	Open-market purchase	Common Stock	100	$27.77	$3K
Jun 26, 2026	Brian C. Stephenson - Officer	Open-market purchase	Common Stock	580	$23.61^{footnote F5}	$14K
Jun 26, 2026	Brian C. Stephenson - Officer	Open-market purchase	Common Stock	4,212	$24.90^{footnote F6}	$105K
Jun 26, 2026	Brian C. Stephenson - Officer	Open-market purchase	Common Stock	1,358	$25.55^{footnote F7}	$35K
Jun 26, 2026	Brian C. Stephenson - Officer	Open-market purchase	Common Stock	100	$26.39	$3K
Footnote F1 (price): The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $24.50 to $25.435, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the… Full note on SEC EDGAR Footnote F3 (price): The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $25.58 to $26.57, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the… Full note on SEC EDGAR Footnote F4 (price): The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $26.61 to $27.52, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the… Full note on SEC EDGAR Footnote F5 (price): The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $23.27 to $24.1663, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the… Full note on SEC EDGAR Footnote F6 (price): The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $24.27 to $25.2405, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the… Full note on SEC EDGAR Footnote F7 (price): The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $25.335 to $26.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the… Full note on SEC EDGAR
Jun 22, 2026	Brian C. Stephenson - Officer	Open-market purchase	Common Stock	1,583	$22.40^{footnote F4}	$35K
Jun 22, 2026	Brian C. Stephenson - Officer	Open-market purchase	Common Stock	3,329	$23.28^{footnote F5}	$77K
Jun 22, 2026	Brian C. Stephenson - Officer	Open-market purchase	Common Stock	356	$23.95^{footnote F6}	$9K
Jun 23, 2026	Brian C. Stephenson - Officer	Open-market purchase	Common Stock	6,836	$24.12^{footnote F7}	$165K
Jun 22, 2026	Brian C. Stephenson - Officer	Open-market purchase	Common Stock	1,797	$20.23^{footnote F1}	$36K
Jun 22, 2026	Brian C. Stephenson - Officer	Open-market purchase	Common Stock	1,118	$20.82^{footnote F3}	$23K
Jun 23, 2026	Brian C. Stephenson - Officer	Open-market purchase	Common Stock	1,969	$24.84^{footnote F8}	$49K
Jun 23, 2026	Brian C. Stephenson - Officer	Open-market purchase	Common Stock	425	$25.91^{footnote F9}	$11K
Footnote F1 (price): The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $19.5765 to $20.545, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of… Full note on SEC EDGAR Footnote F3 (price): The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $20.62 to $21.17, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the… Full note on SEC EDGAR Footnote F4 (price): The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $21.79 to $22.7733, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the… Full note on SEC EDGAR Footnote F5 (price): The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $22.8003 to $23.69, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the… Full note on SEC EDGAR Footnote F6 (price): The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $23.82 to $24.04, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the… Full note on SEC EDGAR Footnote F7 (price): The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $23.62 to $24.59, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the… Full note on SEC EDGAR Footnote F8 (price): The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $24.64 to $25.57, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the… Full note on SEC EDGAR Footnote F9 (price): The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $25.64 to $26.31, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the… Full note on SEC EDGAR
Jun 22, 2026	Anand Kiran Parikh - Officer	Option exercise	Employee Stock Option (right to buy)	45,252	$0.00	-
Jun 22, 2026	Anand Kiran Parikh - Officer	Option exercise	Employee Stock Option (right to buy)	8,213	$0.00	-
Jun 22, 2026	Anand Kiran Parikh - Officer	Open-market purchase	Common Stock	2,806	$19.76	$55K
Jun 22, 2026	Anand Kiran Parikh - Officer	Option exercise	Common Stock	45,252	$1.16	$52K
Jun 22, 2026	Anand Kiran Parikh - Officer	Option exercise	Common Stock	8,213	$1.16	$10K
Jun 12, 2026	Saira Ramasastry	Grant or award	Stock Option (right to buy)	25,000	$0.00	-
Jun 12, 2026	Stephen M. Hahn	Grant or award	Stock Option (right to buy)	25,000	$0.00	-
Jun 15, 2026	Stephen M. Hahn	Other	Series B Preferred Stock	44.76	-^{footnote F2,F3}	-
Jun 15, 2026	Stephen M. Hahn	Other	Common Stock	44,763^{footnote F1}	-^{footnote F2,F3}	-
Footnote F1 (shares): Subject to certain conditions set forth in the Certificate of Designation of Preferences, Rights and Limitations of the Series B Preferred Stock, each share of Series B Preferred Stock is convertible into 1,000 shares of the Issuer's Common Stock and has no expiration date. Footnote F2 (price): Pursuant to February 17, 2026 Agreement and Plan of Merger (the "Merger Agreement"), by and among the Issuer, Sapphire First Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of the Issuer ("First Merger Sub"), Sapphire Second Merger Sub, LLC, a Delaware… Full note on SEC EDGAR Footnote F3 (price): Footnote continued: Upon the closing of the Merger, shares of outstanding common stock of HoldCo were converted into the right to receive shares of the Issuer's Series B Preferred Stock.
Feb 17, 2026	Anand Kiran Parikh - Officer	Grant or award	Series B Preferred Stock	761.43	-	-
Feb 17, 2026	Anand Kiran Parikh - Officer	Grant or award	Employee Stock Option (right to buy)	12,320	-	-
Feb 17, 2026	Anand Kiran Parikh - Officer	Grant or award	Employee Stock Option (right to buy)	136,884	-	-
Jun 10, 2026	Christopher Gerry - Officer	Grant or award	Stock Option (right to buy)	220,000	$0.00	-
Jun 10, 2026	Phillip B. Donenberg	Grant or award	Stock Option (right to buy)	12,500	$0.00	-
Jun 10, 2026	Bob Holmen	Grant or award	Stock Option (right to buy)	12,500	$0.00	-
Jun 1, 2026	Cambrian BioPharma Inc	Open-market sale	Common Stock	476	$21.14	$10K
Jun 1, 2026	Cambrian BioPharma Inc	Open-market sale	Common Stock	24,524	$20.00^{footnote F1}	$490K
Footnote F1 (price): The price reported in Column 4 is a weighted average price. The prices sold ranged from $20.00 to $21.00. The reporting person will provide the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each… Full note on SEC EDGAR
Jun 1, 2026	James Peyer	Open-market sale	Common Stock	476	$21.14	$10K
Jun 1, 2026	James Peyer	Open-market sale	Common Stock	24,524	$20.00^{footnote F1}	$490K
Footnote F1 (price): The price reported in Column 4 is a weighted average price. The prices sold ranged from $20.00 to $21.00. The reporting person will provide the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each… Full note on SEC EDGAR
Apr 7, 2026	MILLENNIUM MANAGEMENT LLC - 10% Owner	Open-market purchase	Common Stock	1,108	$33.38^{footnote F14}	$37K
Apr 2, 2026	MILLENNIUM MANAGEMENT LLC - 10% Owner	Open-market purchase	Common Stock	26	$33.47^{footnote F1}	$870
Apr 2, 2026	MILLENNIUM MANAGEMENT LLC - 10% Owner	Open-market purchase	Common Stock	1,276	$34.75^{footnote F4}	$44K
Apr 2, 2026	MILLENNIUM MANAGEMENT LLC - 10% Owner	Open-market purchase	Common Stock	701	$35.55^{footnote F5}	$25K
Apr 2, 2026	MILLENNIUM MANAGEMENT LLC - 10% Owner	Open-market sale	Common Stock	3,099	$30.86^{footnote F6}	$96K
Apr 2, 2026	MILLENNIUM MANAGEMENT LLC - 10% Owner	Open-market sale	Common Stock	1,265	$31.75^{footnote F7}	$40K
Apr 2, 2026	MILLENNIUM MANAGEMENT LLC - 10% Owner	Open-market sale	Common Stock	1,794	$32.60^{footnote F8}	$58K
Apr 2, 2026	MILLENNIUM MANAGEMENT LLC - 10% Owner	Open-market sale	Common Stock	374	$33.35^{footnote F9}	$12K
Apr 2, 2026	MILLENNIUM MANAGEMENT LLC - 10% Owner	Open-market sale	Common Stock	1,134	$34.80^{footnote F10}	$39K
Apr 6, 2026	MILLENNIUM MANAGEMENT LLC - 10% Owner	Open-market purchase	Common Stock	1,104	$31.02^{footnote F11}	$34K
Apr 6, 2026	MILLENNIUM MANAGEMENT LLC - 10% Owner	Open-market sale	Common Stock	1,214	$31.02^{footnote F12}	$38K
Apr 6, 2026	MILLENNIUM MANAGEMENT LLC - 10% Owner	Open-market sale	Common Stock	45	$31.96^{footnote F13}	$1K
Apr 7, 2026	MILLENNIUM MANAGEMENT LLC - 10% Owner	Open-market sale	Common Stock	2,115	$28.94^{footnote F15}	$61K
Apr 7, 2026	MILLENNIUM MANAGEMENT LLC - 10% Owner	Open-market sale	Common Stock	205	$29.71^{footnote F16}	$6K
Apr 7, 2026	MILLENNIUM MANAGEMENT LLC - 10% Owner	Open-market sale	Common Stock	4,423	$31.38^{footnote F17}	$139K
Apr 7, 2026	MILLENNIUM MANAGEMENT LLC - 10% Owner	Open-market sale	Common Stock	300	$32.25^{footnote F18}	$10K
Apr 7, 2026	MILLENNIUM MANAGEMENT LLC - 10% Owner	Open-market sale	Common Stock	1,108	$33.38^{footnote F19}	$37K
Footnote F1 (price): Represents volume-weighted average price ("VWAP") of purchases of 26 shares of common stock ("Common Stock"), par value $0.0001 per share, of Sensei Biotherapeutics, Inc. (the "Company") on April 2, 2026 at prices ranging from $32.90 to $33.62. Upon request by the Commission… Full note on SEC EDGAR Footnote F4 (price): Represents VWAP of purchases of 1,276 shares of the Company's Common Stock on April 2, 2026 at prices ranging from $33.97 to $34.90. Footnote F5 (price): Represents VWAP of purchases of 701 shares of the Company's Common Stock on April 2, 2026 at prices ranging from $35.4481 to $35.91. Footnote F6 (price): Represents VWAP of sales of 3,099 shares of the Company's Common Stock on April 2, 2026 at prices ranging from $30.1332 to $31.1212. Footnote F7 (price): Represents VWAP of sales of 1,265 shares of the Company's Common Stock on April 2, 2026 at prices ranging from $31.21 to $32.15. Footnote F8 (price): Represents VWAP of sales of 1,794 shares of the Company's Common Stock on April 2, 2026 at prices ranging from $32.22 to $33.1251. Footnote F9 (price): Represents VWAP of sales of 374 shares of the Company's Common Stock on April 2, 2026 at prices ranging from $33.23 to $33.45. Footnote F10 (price): Represents VWAP of sales of 1,134 shares of the Company's Common Stock on April 2, 2026 at prices ranging from $34.40 to $35.25. Footnote F11 (price): Represents purchases of 1,104 shares of the Company's Common Stock on April 6, 2026 at $31.02 per share. Footnote F12 (price): Represents VWAP of sales of 1,214 shares of the Company's Common Stock on April 6, 2026 at prices ranging from $30.64 to $31.345. Footnote F13 (price): Represents VWAP of sales of 45 shares of the Company's Common Stock on April 6, 2026 at prices ranging from $31.80 to $32.17. Footnote F14 (price): Represents VWAP of purchases of 1,108 shares of the Company's Common Stock on April 7, 2026 at $33.38 per share. Footnote F15 (price): Represents VWAP of sales of 2,115 shares of the Company's Common Stock on April 7, 2026 at prices ranging from $28.5071 to $29.3167. Footnote F16 (price): Represents VWAP of sales of 205 shares of the Company's Common Stock on April 7, 2026 at prices ranging from $29.695 to $30.50. Footnote F17 (price): Represents VWAP of sales of 4,423 shares of the Company's Common Stock on April 7, 2026 at prices ranging from $30.9852 to $31.813. Footnote F18 (price): Represents VWAP of sales of 300 shares of the Company's Common Stock on April 7, 2026 at prices ranging from $32.0625 to $32.615. Footnote F19 (price): Represents sales of 1,108 shares of the Company's Common Stock on April 7, 2026 at $33.38 per share.
Apr 10, 2026	Josiah Craver - Officer	Grant or award	Stock Option (right to buy)	80,000	$0.00	-
Apr 10, 2026	Phillip B. Donenberg	Grant or award	Stock Option (right to buy)	23,100	$0.00	-
Feb 17, 2026	Anand Kiran Parikh - Officer	Grant or award	Series B Preferred Stock	809,822	-^{footnote F2,F3}	-
Feb 19, 2026	Anand Kiran Parikh - Officer	Grant or award	Employee Stock Option (right to buy)	1,239,305	$0.00	-
Feb 17, 2026	Anand Kiran Parikh - Officer	Grant or award	Employee Stock Option (right to buy)	92,533	-^{footnote F4}	-
Feb 17, 2026	Anand Kiran Parikh - Officer	Grant or award	Employee Stock Option (right to buy)	56,673	-^{footnote F6}	-
Footnote F2 (price): Received in exchange for 4,062,777 shares of common stock of Faeth Holdings Therapeutics, Inc. ("HoldCo") pursuant to an Agreement and Plan of Merger, dated February 17, 2026 (the "Merger Agreement"), by and among the Company, Sapphire First Merger Sub, Inc., a Delaware… Full note on SEC EDGAR Footnote F3 (price): Under the terms of the Merger Agreement, on February 17, 2026, First Merger Sub merged with and into HoldCo, with HoldCo surviving the first merger as a wholly owned subsidiary of the Company, and immediately following the first merger, HoldCo merged with and into Second Merger… Full note on SEC EDGAR Footnote F4 (price): Received in exchange for a stock option to acquire 464,222 shares of Faeth common stock with an exercise price of $0.23 per share pursuant to the Merger Agreement. Footnote F6 (price): Received in exchange for stock options to acquire an aggregate of 284,320 shares of Faeth common stock with an exercise price of $0.23 per share pursuant to the Merger Agreement.
Feb 13, 2026	Phillip B. Donenberg	Grant or award	Stock Option (right to buy)	1,900	$0.00	-
May 21, 2025	William R. Ringo	Grant or award	Stock Option (Right to Buy)	19,000	$0.00	-
May 21, 2025	Thomas G. Ricks	Grant or award	Stock Option (Right to Buy)	19,000	$0.00	-
Dec 20, 2024	Stephanie Krebs - Officer	Grant or award	Stock Option (Right to Buy)	120,000	$0.00	-
Dec 20, 2024	der Horst Edward van - Officer	Grant or award	Stock Option (Right to Buy)	100,000	$0.00	-
Dec 20, 2024	Josiah Craver - Officer	Grant or award	Stock Option (Right to Buy)	100,000	$0.00	-
Dec 20, 2024	John Celebi - Officer	Grant or award	Stock Option (Right to Buy)	355,000	$0.00	-

Recent FTH Form 8-K filings

Read FTH company news

Sep 17, 2026Item 5.02

Read the filing on SEC EDGAR

Aug 4, 2026Item 2.02, 9.01

Read the filing on SEC EDGAR

Jul 23, 2026Item 5.02

Read the filing on SEC EDGAR

Jun 18, 2026Item 1.01, 8.01, 9.01

Read the filing on SEC EDGAR

Recent FTH Form 144 notices of proposed sale

An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.

Filed	Filer	Relationship	Shares	Market value	Notice
Aug 11, 2026	Cambrian BioPharma Inc	10% Stockholder	130,142	$3.64M	View on EDGAR
Apr 29, 2026	-	-	-	-

FTH insider trading FAQ

What is the latest insider trade for FTH?

Faeth Therapeutics, Inc. (FTH) had 3 insider filings in the last 90 days, with the most recent on 2026-09-15. The full record for FTH runs to 26 Form 4 filings, the earliest from 2024-12-23. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.

How many insiders are buying FTH stock?

No insider purchases of FTH were filed in the last 90 days. 28 purchases are on record for this company.

How many insiders are selling FTH stock?

No insider sales of FTH were filed in the last 90 days. 16 sales are on record for this company.

Where can I see FTH SEC filings (Form 4, 10-K, 10-Q, 8-K)?

This page collects FTH Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.

More Health Care companies with insider activity

Recent insider filings

The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.

Sep 15, 2026 - Karen H. Vousden view on EDGAR
Jul 23, 2026 - Josiah Craver view on EDGAR
Jul 23, 2026 - Anand Kiran Parikh view on EDGAR
Jul 2, 2026 - Brian C. Stephenson view on EDGAR
Jun 26, 2026 - Brian C. Stephenson view on EDGAR
Jun 24, 2026 - Brian C. Stephenson view on EDGAR
Jun 24, 2026 - Anand Kiran Parikh view on EDGAR
Jun 16, 2026 - Saira Ramasastry view on EDGAR
Jun 16, 2026 - Stephen M. Hahn view on EDGAR

Related companies with recent insider activity

Learn more

What the Form 4 transaction codes mean: Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
Form 144 vs Form 4: A Form 144 announces a planned sale; the Form 4 reports it after it happens.
Insider activity in Health Care: Where FTH's peers are being bought and sold.
Every recent Form 4: The market-wide feed, updated as filings arrive from SEC EDGAR.

Follow FTH with a 7-day demo

FTH on your watchlist
Every FTH Form 4 filing on record
Up to 3 months of FTH price history
The daily trading plan of ranked insider buys, on a delay, with the plan archive

Start 7-day demoCard required. Your card is never charged for the demo.

Form 4 transaction type

Transactions

Total value

Grant or award

453,842

Date

Insider

Transaction

Security

Price

Value

Sep 11, 2026

Karen H. Vousden - Director

Grant or award

Stock Option (right to buy)

25,000

$0.00

Jul 21, 2026

Josiah Craver - Officer

Grant or award

Performance-Based Stock Option (right to buy)

30,824

$0.00

Jul 21, 2026

Anand Kiran Parikh - Officer

Grant or award

Performance-Based Stock Option (right to buy)

398,018

$0.00

Jun 29, 2026

Brian C. Stephenson - Officer

Open-market purchase

Common Stock

831

$23.34^{footnote F1}

$19K

Jun 30, 2026

Brian C. Stephenson - Officer

Open-market purchase

Common Stock

1,910

$22.95^{footnote F3}

$44K

Jun 30, 2026

Brian C. Stephenson - Officer

Open-market purchase

Common Stock

1,638

$23.88^{footnote F4}

$39K

Jun 30, 2026

Brian C. Stephenson - Officer

Open-market purchase

Common Stock

4,255

$24.98^{footnote F5}

$106K

Jul 1, 2026

Brian C. Stephenson - Officer

Open-market purchase

Common Stock

4,400

$23.40^{footnote F6}

$103K

Jul 1, 2026

Brian C. Stephenson - Officer

Open-market purchase

Common Stock

600

$24.22^{footnote F7}

$15K

Footnote F1 (price): The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $23.20 to $23.49, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the… Full note on SEC EDGAR
Footnote F3 (price): The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $22.45 to $23.28, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the… Full note on SEC EDGAR
Footnote F4 (price): The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $23.50 to $24.40, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the… Full note on SEC EDGAR
Footnote F5 (price): The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $24.59 to $25.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the… Full note on SEC EDGAR
Footnote F6 (price): The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $23.14 to $23.94, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the… Full note on SEC EDGAR
Footnote F7 (price): The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $24.14 to $24.29, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the… Full note on SEC EDGAR

Jun 24, 2026

Brian C. Stephenson - Officer

Open-market purchase

Common Stock

2,891

$25.22^{footnote F1}

$73K

Jun 24, 2026

Brian C. Stephenson - Officer

Open-market purchase

Common Stock

3,000

$25.98^{footnote F3}

$78K

Jun 24, 2026

Brian C. Stephenson - Officer

Open-market purchase

Common Stock

3,400

$26.98^{footnote F4}

$92K

Jun 24, 2026

Brian C. Stephenson - Officer

Open-market purchase

Common Stock

100

$27.77

$3K

Jun 26, 2026

Brian C. Stephenson - Officer

Open-market purchase

Common Stock

580

$23.61^{footnote F5}

$14K

Jun 26, 2026

Brian C. Stephenson - Officer

Open-market purchase

Common Stock

4,212

$24.90^{footnote F6}

$105K

Jun 26, 2026

Brian C. Stephenson - Officer

Open-market purchase

Common Stock

1,358

$25.55^{footnote F7}

$35K

Jun 26, 2026

Brian C. Stephenson - Officer

Open-market purchase

Common Stock

100

$26.39

$3K

Footnote F1 (price): The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $24.50 to $25.435, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the… Full note on SEC EDGAR
Footnote F3 (price): The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $25.58 to $26.57, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the… Full note on SEC EDGAR
Footnote F4 (price): The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $26.61 to $27.52, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the… Full note on SEC EDGAR
Footnote F5 (price): The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $23.27 to $24.1663, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the… Full note on SEC EDGAR
Footnote F6 (price): The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $24.27 to $25.2405, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the… Full note on SEC EDGAR
Footnote F7 (price): The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $25.335 to $26.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the… Full note on SEC EDGAR

Jun 22, 2026

Brian C. Stephenson - Officer

Open-market purchase

Common Stock

1,583

$22.40^{footnote F4}

$35K

Jun 22, 2026

Brian C. Stephenson - Officer

Open-market purchase

Common Stock

3,329

$23.28^{footnote F5}

$77K

Jun 22, 2026

Brian C. Stephenson - Officer

Open-market purchase

Common Stock

356

$23.95^{footnote F6}

$9K

Jun 23, 2026

Brian C. Stephenson - Officer

Open-market purchase

Common Stock

6,836

$24.12^{footnote F7}

$165K

Jun 22, 2026

Brian C. Stephenson - Officer

Open-market purchase

Common Stock

1,797

$20.23^{footnote F1}

$36K

Jun 22, 2026

Brian C. Stephenson - Officer

Open-market purchase

Common Stock

1,118

$20.82^{footnote F3}

$23K

Jun 23, 2026

Brian C. Stephenson - Officer

Open-market purchase

Common Stock

1,969

$24.84^{footnote F8}

$49K

Jun 23, 2026

Brian C. Stephenson - Officer

Open-market purchase

Common Stock

425

$25.91^{footnote F9}

$11K

Footnote F1 (price): The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $19.5765 to $20.545, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of… Full note on SEC EDGAR
Footnote F3 (price): The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $20.62 to $21.17, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the… Full note on SEC EDGAR
Footnote F4 (price): The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $21.79 to $22.7733, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the… Full note on SEC EDGAR
Footnote F5 (price): The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $22.8003 to $23.69, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the… Full note on SEC EDGAR
Footnote F6 (price): The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $23.82 to $24.04, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the… Full note on SEC EDGAR
Footnote F7 (price): The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $23.62 to $24.59, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the… Full note on SEC EDGAR
Footnote F8 (price): The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $24.64 to $25.57, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the… Full note on SEC EDGAR
Footnote F9 (price): The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $25.64 to $26.31, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the… Full note on SEC EDGAR

Jun 22, 2026

Anand Kiran Parikh - Officer

Option exercise

Employee Stock Option (right to buy)

45,252

$0.00

Jun 22, 2026

Anand Kiran Parikh - Officer

Option exercise

Employee Stock Option (right to buy)

8,213

$0.00

Jun 22, 2026

Anand Kiran Parikh - Officer

Open-market purchase

Common Stock

2,806

$19.76

$55K

Jun 22, 2026

Anand Kiran Parikh - Officer

Option exercise

Common Stock

45,252

$1.16

$52K

Jun 22, 2026

Anand Kiran Parikh - Officer

Option exercise

Common Stock

8,213

$1.16

$10K

Jun 12, 2026

Saira Ramasastry

Grant or award

Stock Option (right to buy)

25,000

$0.00

Jun 12, 2026

Stephen M. Hahn

Grant or award

Stock Option (right to buy)

25,000

$0.00

Jun 15, 2026

Stephen M. Hahn

Other

Series B Preferred Stock

44.76

-^{footnote F2,F3}

Jun 15, 2026

Stephen M. Hahn

Other

Common Stock

44,763^{footnote F1}

-^{footnote F2,F3}

Footnote F1 (shares): Subject to certain conditions set forth in the Certificate of Designation of Preferences, Rights and Limitations of the Series B Preferred Stock, each share of Series B Preferred Stock is convertible into 1,000 shares of the Issuer's Common Stock and has no expiration date.
Footnote F2 (price): Pursuant to February 17, 2026 Agreement and Plan of Merger (the "Merger Agreement"), by and among the Issuer, Sapphire First Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of the Issuer ("First Merger Sub"), Sapphire Second Merger Sub, LLC, a Delaware… Full note on SEC EDGAR
Footnote F3 (price): Footnote continued: Upon the closing of the Merger, shares of outstanding common stock of HoldCo were converted into the right to receive shares of the Issuer's Series B Preferred Stock.

Feb 17, 2026

Anand Kiran Parikh - Officer

Grant or award

Series B Preferred Stock

761.43

Feb 17, 2026

Anand Kiran Parikh - Officer

Grant or award

Employee Stock Option (right to buy)

12,320

Feb 17, 2026

Anand Kiran Parikh - Officer

Grant or award

Employee Stock Option (right to buy)

136,884

Jun 10, 2026

Christopher Gerry - Officer

Grant or award

Stock Option (right to buy)

220,000

$0.00

Jun 10, 2026

Phillip B. Donenberg

Grant or award

Stock Option (right to buy)

12,500

$0.00

Jun 10, 2026

Bob Holmen

Grant or award

Stock Option (right to buy)

12,500

$0.00

Jun 1, 2026

Cambrian BioPharma Inc

Open-market sale

Common Stock

476

$21.14

$10K

Jun 1, 2026

Cambrian BioPharma Inc

Open-market sale

Common Stock

24,524

$20.00^{footnote F1}

$490K

Footnote F1 (price): The price reported in Column 4 is a weighted average price. The prices sold ranged from $20.00 to $21.00. The reporting person will provide the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each… Full note on SEC EDGAR

Jun 1, 2026

James Peyer

Open-market sale

Common Stock

476

$21.14

$10K

Jun 1, 2026

James Peyer

Open-market sale

Common Stock

24,524

$20.00^{footnote F1}

$490K

Footnote F1 (price): The price reported in Column 4 is a weighted average price. The prices sold ranged from $20.00 to $21.00. The reporting person will provide the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each… Full note on SEC EDGAR

Apr 7, 2026

MILLENNIUM MANAGEMENT LLC - 10% Owner

Open-market purchase

Common Stock

1,108

$33.38^{footnote F14}

$37K

Apr 2, 2026

MILLENNIUM MANAGEMENT LLC - 10% Owner

Open-market purchase

Common Stock

$33.47^{footnote F1}

$870

Apr 2, 2026

MILLENNIUM MANAGEMENT LLC - 10% Owner

Open-market purchase

Common Stock

1,276

$34.75^{footnote F4}

$44K

Apr 2, 2026

MILLENNIUM MANAGEMENT LLC - 10% Owner

Open-market purchase

Common Stock

701

$35.55^{footnote F5}

$25K

Apr 2, 2026

MILLENNIUM MANAGEMENT LLC - 10% Owner

Open-market sale

Common Stock

3,099

$30.86^{footnote F6}

$96K

Apr 2, 2026

MILLENNIUM MANAGEMENT LLC - 10% Owner

Open-market sale

Common Stock

1,265

$31.75^{footnote F7}

$40K

Apr 2, 2026

MILLENNIUM MANAGEMENT LLC - 10% Owner

Open-market sale

Common Stock

1,794

$32.60^{footnote F8}

$58K

Apr 2, 2026

MILLENNIUM MANAGEMENT LLC - 10% Owner

Open-market sale

Common Stock

374

$33.35^{footnote F9}

$12K

Apr 2, 2026

MILLENNIUM MANAGEMENT LLC - 10% Owner

Open-market sale

Common Stock

1,134

$34.80^{footnote F10}

$39K

Apr 6, 2026

MILLENNIUM MANAGEMENT LLC - 10% Owner

Open-market purchase

Common Stock

1,104

$31.02^{footnote F11}

$34K

Apr 6, 2026

MILLENNIUM MANAGEMENT LLC - 10% Owner

Open-market sale

Common Stock

1,214

$31.02^{footnote F12}

$38K

Apr 6, 2026

MILLENNIUM MANAGEMENT LLC - 10% Owner

Open-market sale

Common Stock

$31.96^{footnote F13}

$1K

Apr 7, 2026

MILLENNIUM MANAGEMENT LLC - 10% Owner

Open-market sale

Common Stock

2,115

$28.94^{footnote F15}

$61K

Apr 7, 2026

MILLENNIUM MANAGEMENT LLC - 10% Owner

Open-market sale

Common Stock

205

$29.71^{footnote F16}

$6K

Apr 7, 2026

MILLENNIUM MANAGEMENT LLC - 10% Owner

Open-market sale

Common Stock

4,423

$31.38^{footnote F17}

$139K

Apr 7, 2026

MILLENNIUM MANAGEMENT LLC - 10% Owner

Open-market sale

Common Stock

300

$32.25^{footnote F18}

$10K

Apr 7, 2026

MILLENNIUM MANAGEMENT LLC - 10% Owner

Open-market sale

Common Stock

1,108

$33.38^{footnote F19}

$37K

Footnote F1 (price): Represents volume-weighted average price ("VWAP") of purchases of 26 shares of common stock ("Common Stock"), par value $0.0001 per share, of Sensei Biotherapeutics, Inc. (the "Company") on April 2, 2026 at prices ranging from $32.90 to $33.62. Upon request by the Commission… Full note on SEC EDGAR
Footnote F4 (price): Represents VWAP of purchases of 1,276 shares of the Company's Common Stock on April 2, 2026 at prices ranging from $33.97 to $34.90.
Footnote F5 (price): Represents VWAP of purchases of 701 shares of the Company's Common Stock on April 2, 2026 at prices ranging from $35.4481 to $35.91.
Footnote F6 (price): Represents VWAP of sales of 3,099 shares of the Company's Common Stock on April 2, 2026 at prices ranging from $30.1332 to $31.1212.
Footnote F7 (price): Represents VWAP of sales of 1,265 shares of the Company's Common Stock on April 2, 2026 at prices ranging from $31.21 to $32.15.
Footnote F8 (price): Represents VWAP of sales of 1,794 shares of the Company's Common Stock on April 2, 2026 at prices ranging from $32.22 to $33.1251.
Footnote F9 (price): Represents VWAP of sales of 374 shares of the Company's Common Stock on April 2, 2026 at prices ranging from $33.23 to $33.45.
Footnote F10 (price): Represents VWAP of sales of 1,134 shares of the Company's Common Stock on April 2, 2026 at prices ranging from $34.40 to $35.25.
Footnote F11 (price): Represents purchases of 1,104 shares of the Company's Common Stock on April 6, 2026 at $31.02 per share.
Footnote F12 (price): Represents VWAP of sales of 1,214 shares of the Company's Common Stock on April 6, 2026 at prices ranging from $30.64 to $31.345.
Footnote F13 (price): Represents VWAP of sales of 45 shares of the Company's Common Stock on April 6, 2026 at prices ranging from $31.80 to $32.17.
Footnote F14 (price): Represents VWAP of purchases of 1,108 shares of the Company's Common Stock on April 7, 2026 at $33.38 per share.
Footnote F15 (price): Represents VWAP of sales of 2,115 shares of the Company's Common Stock on April 7, 2026 at prices ranging from $28.5071 to $29.3167.
Footnote F16 (price): Represents VWAP of sales of 205 shares of the Company's Common Stock on April 7, 2026 at prices ranging from $29.695 to $30.50.
Footnote F17 (price): Represents VWAP of sales of 4,423 shares of the Company's Common Stock on April 7, 2026 at prices ranging from $30.9852 to $31.813.
Footnote F18 (price): Represents VWAP of sales of 300 shares of the Company's Common Stock on April 7, 2026 at prices ranging from $32.0625 to $32.615.
Footnote F19 (price): Represents sales of 1,108 shares of the Company's Common Stock on April 7, 2026 at $33.38 per share.

Apr 10, 2026

Josiah Craver - Officer

Grant or award

Stock Option (right to buy)

80,000

$0.00

Apr 10, 2026

Phillip B. Donenberg

Grant or award

Stock Option (right to buy)

23,100

$0.00

Feb 17, 2026

Anand Kiran Parikh - Officer

Grant or award

Series B Preferred Stock

809,822

-^{footnote F2,F3}

Feb 19, 2026

Anand Kiran Parikh - Officer

Grant or award

Employee Stock Option (right to buy)

1,239,305

$0.00

Feb 17, 2026

Anand Kiran Parikh - Officer

Grant or award

Employee Stock Option (right to buy)

92,533

-^{footnote F4}

Feb 17, 2026

Anand Kiran Parikh - Officer

Grant or award

Employee Stock Option (right to buy)

56,673

-^{footnote F6}

Footnote F2 (price): Received in exchange for 4,062,777 shares of common stock of Faeth Holdings Therapeutics, Inc. ("HoldCo") pursuant to an Agreement and Plan of Merger, dated February 17, 2026 (the "Merger Agreement"), by and among the Company, Sapphire First Merger Sub, Inc., a Delaware… Full note on SEC EDGAR
Footnote F3 (price): Under the terms of the Merger Agreement, on February 17, 2026, First Merger Sub merged with and into HoldCo, with HoldCo surviving the first merger as a wholly owned subsidiary of the Company, and immediately following the first merger, HoldCo merged with and into Second Merger… Full note on SEC EDGAR
Footnote F4 (price): Received in exchange for a stock option to acquire 464,222 shares of Faeth common stock with an exercise price of $0.23 per share pursuant to the Merger Agreement.
Footnote F6 (price): Received in exchange for stock options to acquire an aggregate of 284,320 shares of Faeth common stock with an exercise price of $0.23 per share pursuant to the Merger Agreement.

Feb 13, 2026

Phillip B. Donenberg

Grant or award

Stock Option (right to buy)

1,900

$0.00

May 21, 2025

William R. Ringo

Grant or award

Stock Option (Right to Buy)

19,000

$0.00

May 21, 2025

Thomas G. Ricks

Grant or award

Stock Option (Right to Buy)

19,000

$0.00

Dec 20, 2024

Stephanie Krebs - Officer

Grant or award

Stock Option (Right to Buy)

120,000

$0.00

Dec 20, 2024

der Horst Edward van - Officer

Grant or award

Stock Option (Right to Buy)

100,000

$0.00

Dec 20, 2024

Josiah Craver - Officer

Grant or award

Stock Option (Right to Buy)

100,000

$0.00

Dec 20, 2024

John Celebi - Officer

Grant or award

Stock Option (Right to Buy)

355,000

$0.00

Filed

Filer

Relationship

Market value

Notice

Aug 11, 2026

Cambrian BioPharma Inc

10% Stockholder

130,142

$3.64M

View on EDGAR

Apr 29, 2026